A detailed history of Tfb Advisors LLC transactions in Dexcom Inc stock. As of the latest transaction made, Tfb Advisors LLC holds 2,569 shares of DXCM stock, worth $179,367. This represents 0.1% of its overall portfolio holdings.

Number of Shares
2,569
Previous 2,333 10.12%
Holding current value
$179,367
Previous $323,000 9.91%
% of portfolio
0.1%
Previous 0.11%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$110.31 - $140.45 $26,033 - $33,146
236 Added 10.12%
2,569 $291,000
Q1 2024

May 03, 2024

BUY
$114.22 - $140.1 $266,475 - $326,853
2,333 New
2,333 $323,000
Q2 2023

Jul 18, 2023

BUY
$112.47 - $130.98 $25,305 - $29,470
225 Added 11.21%
2,232 $286,000
Q1 2023

Apr 10, 2023

BUY
$104.0 - $122.92 $20,072 - $23,723
193 Added 10.64%
2,007 $233,000
Q4 2022

Feb 14, 2023

BUY
$84.98 - $122.67 $154,153 - $222,523
1,814 New
1,814 $205,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $27B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Tfb Advisors LLC Portfolio

Follow Tfb Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tfb Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tfb Advisors LLC with notifications on news.